Vaxcel Pantoprazole

Vaxcel Pantoprazole



Kotra Pharma


Kotra Pharma
Concise Prescribing Info
Pantoprazole Na
Short-term use for symptomatic improvement & healing of GI diseases which require acid secretion reduction eg, duodenal & gastric ulcer, moderate & severe reflux esophagitis, Zollinger-Ellison syndrome & other pathological hypersecretory conditions.
Dosage/Direction for Use
Long-term management of Zollinger-Ellison syndrome & other pathological hypersecretory conditions Recommended daily dose: 80 mg. Duration of treatment: Not to exceed 8 wk. Rapid acid control Starting dose: 2 x 80 mg w/in 1 hr.
Hypersensitivity. Administration w/ atazanavir.
Special Precautions
Not for mild GI complaints eg, nervous dyspepsia. Exclude possibility of gastric or esophageal malignancy. Renal impairment & severe hepatic impairment. Discontinue use in case of increased liver enzyme. Pregnancy & lactation. Elderly.
Adverse Reactions
Upper abdominal pain, diarrhea, constipation, flatulence; headache.
Drug Interactions
Changed absorption w/ ketoconazole. Monitor prothrombin time or INR w/ phenprocoumon or warfarin. Reduced atazanavir bioavailability.
ATC Classification
A02BC02 - pantoprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Vaxcel Pantoprazole powd for inj 40 mg
10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in